Université Libre de Bruxelles
Preclinical efficacy assessment of CDK4/6 inhibitory drugs in aggressive thyroid cancers and evaluation of phosphorylated CDK4 as sensitivity biomarker.
2020
Ixelles
Soutien au projet de recherche : 'Preclinical efficacy assessment of CDK4/6 inhibitory drugs in aggressive thyroid cancers and evaluation of phosphorylated CDK4 as sensitivity biomarker'.